Chungue E, Poli L, Roche C, Gestas P, Glaziou P, Markoff L J
Institut Territorial de Recherches Médicales Louis Malardé, Papeete, Tahiti.
J Infect Dis. 1994 Nov;170(5):1304-7. doi: 10.1093/infdis/170.5.1304.
Although dengue fever (DF) is usually self-limited, some patients experience severe and prolonged illness characterized by capillary leakage, which may progress to hypovolemic shock (dengue hemorrhagic fever/dengue shock syndrome; DHF/DSS) with hemorrhage of unknown etiology. Development of antibodies potentially cross-reactive to plasminogen has been reported in a high percentage of Thai patients with DF and DHF/DSS. Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage was evaluated in 88 Tahitian children with dengue virus type 3 infection who presented with (n = 59) or without (n = 29) hemorrhage. Plasminogen cross-reactive antibodies were found in acute and convalescent sera of 33 and 11 children, respectively (56% vs. 31%, P < .05), and closely paralleled antibodies to the cross-reactive site in dengue virus E protein. Antibodies were more frequent in children with secondary than primary infections (60% vs. 32%, P < .05). Plasminogen cross-reactive antibodies did not correlate with occurrence of DHF/DSS or thrombocytopenia. These results are consistent with the possibility that plasminogen cross-reactive antibodies play a role in the etiology of hemorrhage in dengue virus infection.
虽然登革热通常为自限性疾病,但一些患者会经历严重且病程迁延的疾病,其特征为毛细血管渗漏,这可能会发展为病因不明的出血性低血容量休克(登革出血热/登革休克综合征;DHF/DSS)。据报道,在泰国患有登革热及DHF/DSS的患者中,有很大比例会产生可能与纤溶酶原发生交叉反应的抗体。在88名感染3型登革病毒的塔希提儿童中,评估了纤溶酶原交叉反应抗体检测与出血之间的相关性,这些儿童有出血症状(n = 59)或无出血症状(n = 29)。分别在33名和11名儿童的急性期和恢复期血清中发现了纤溶酶原交叉反应抗体(56%对31%,P < 0.05),且与登革病毒E蛋白交叉反应位点的抗体密切平行。继发感染儿童中的抗体比原发感染儿童更常见(60%对32%,P < 0.05)。纤溶酶原交叉反应抗体与DHF/DSS的发生或血小板减少无关。这些结果与纤溶酶原交叉反应抗体在登革病毒感染出血病因中起作用的可能性一致。